Related Experiment Video
Updated: Feb 14, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
Idiopathic pulmonary fibrosis: A guide for nurse practitioners
Michelle Vega-Olivo1, Gerard J Criner
1Michelle Vega-Olivo is a CRNP, FNP-BC at Temple University, Philadelphia, Pa. Gerard J. Criner is a professor and chair at the Department of Thoracic Medicine and Surgery at Temple University, School of Medicine, Philadelphia, Pa.
Abstract:
Idiopathic pulmonary fibrosis (IPF) is a rare disease characterized by decline in lung function, dyspnea, and cough. The clinical course of IPF is variable and unpredictable. Early referral to specialists is key to ensure timely and accurate diagnosis. Two antifibrotic drugs (nintedanib and pirfenidone) have been approved for the treatment of IPF.
More Related Videos
Related Concept Videos
Pulmonary Embolism III: Nursing Management
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Nursing Interventions I: Taxonomy of Nursing Interventions
A nursing intervention is a treatment or action based on scientific concepts and knowledge from the nursing, behavioral, and physical sciences. Identifying and prioritizing nursing interventions based on the desired outcome...
Nursing Interventions II: Selecting and Classifying the Nursing Interventions

